Coronavirus

George Mason University researchers are taking advantage of DNA molecules’ self-assembly properties to develop vaccines rapidly, publishing their findings in Communications Biology

Researchers led by Professors Farrokh Alemi and Janusz Wojtusiak found that computerized symptom screenings can supplement at-home COVID-19 tests to better confirm the diagnosis for patients and clinicians.

Professor of public health Dr. Amira Roess shares why it is imperative we all get the latest COVID vaccine

A new study by Dongqing Wang, assistant professor of Global and Community Health, finds there is high COVID-19 vaccine hesitancy among adolescents in five sub-Saharan African countries mostly because of perceived lack of safety and perceived lack of effectiveness of COVID-19 vaccines. 

The Fast Grants program within the Mercatus Center will aid in the development of a potential pan-coronavirus vaccine.

George Mason University’s outstanding location, available opportunities, and growing reputation combined to produce a winning formula that attracted statistics professor Lily Wang to the College of Engineering and Computing Department of Statistics in fall 2021.

Mason's Michael Buschmann and his team have developed technology that could help make COVID-19 vaccines less costly, with fewer side-effects and more available.

Since the coronavirus pandemic began, experts have been analyzing data sets to try to predict the number of people who will be infected with the virus. Using nationwide statistics for COVID-19, a Mason electrical engineering master’s student tested a computational method to estimate new infections each day.